MoS Health Tells Rajya Sabha :Increase in Antibodies Post Covaxin Booster Dose Medical Dialogues Bureau31 March 2022 11:10 AM GMTNew Delhi: An ICMR study to examine the effect of Covaxin's booster dose has shown an increase in the levels of antibodies against SARS-CoV-2,...
AstraZeneca Evusheld recommended for approval in EU for prevention of COVID Ruchika Sharma27 March 2022 4:00 AM GMTThe recommended dose of Evusheld in Europe is 150 mg of tixagevimab and 150mg of cilgavimab, administered as two separate sequential intramuscular...
Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 12:38 PM GMTBristol asked the Delaware court for an undisclosed amount of monetary damages.
Mylan Pharma gets USFDA nod for Breyna for Generic Version of Symbicort MD Bureau17 March 2022 9:59 AM GMTViatris Inc. and Kindeva Drug Delivery L.P. today announced that Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug...
No USFDA approval for AstraZeneca's treatment for chronic nasal condition MD Bureau15 March 2022 9:32 AM GMTThe London-listed drugmaker said the U.S. Food and Drug Administration (FDA) had issued a complete response letter following AstraZeneca's application ...
AstraZeneca's Young Health Program opens 3 Health Information Centres (HICs) in Bangalore MD Bureau12 March 2022 9:30 AM GMTThe three HICs at Mahadevpura, Dasarahalli and Yelahanka are developed under Astrazeneca's flagship CSR initiative 'Young Health Programme' that aims...
ISN and AstraZeneca announce multi-year partnership for KCD MD Bureau9 March 2022 9:05 AM GMTChronic Kidney Disease (CKD) today has become a major cause of global mortality and morbidity.
AstraZeneca and Neurimmune collaborate to develop and commercialize NI006 MD Bureau2 March 2022 7:45 AM GMTNI006 is an investigational human monoclonal antibody that specifically targets misfolded transthyretin.
AstraZeneca, Honeywell to collaborate to develop next-generation respiratory inhalers MD Bureau25 Feb 2022 9:32 AM GMTUK: AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less ...
Positive result of Enhertu in DESTINY-Breast04 trial: AstraZeneca Ruchika Sharma22 Feb 2022 6:00 AM GMTUK: In a significant development, AstraZeneca has announced the positive high-level results from the pivotal DESTINY-Breast04 Phase III...
USFDA to allow export of AstraZeneca COVID vaccine lots made at Emergent facility Ruchika Sharma20 Feb 2022 4:15 AM GMTNew Delhi: The U.S. Food and Drug Administration said on Friday it had found four batches of AstraZeneca Plc's COVID-19 vaccine manufactured at...
Concerns mount on short shelf life of AstraZeneca COVID vaccine Ruchika Sharma17 Feb 2022 7:18 AM GMTThe main problem is the vaccine's shelf life of just six months from the date of bottling, the shortest among COVAX's top suppliers, several COVAX and ...
